Monday, 17 January 2011

Genzyme details market potential of Alemtuzumab for MS

Wow! Let's hope it is not too expensive for the NHS.

Click here to read the press release!

No comments:

Post a Comment

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.